This is an edited version of the letter sent on 11 May 2026 to the ‘cannabis cluster’ of government departments – Health, Trade, Industry and Competition, Agriculture and Justuce, accompanying the draft ‘White Paper’ to govern cannabis edibles. A White Paper is a policy formulation in a legislative format that can be presented to Parliament.
With reference to our submission to the DTIC Parliamentary Portfolio Committee on 6 March 2026, together with subsequent policy and stakeholder submissions made in relation to cannabis regulatory reform, we respectfully wish to raise a matter of growing public health concern relating to the circulation of cannabis edible products in South Africa and the urgent need for a coordinated regulatory response.
Cannabis edible products, including sweets, chocolates, baked goods, beverages and other infused consumables, present a distinct risk profile when distributed without proper dosage information, warning labels, child-resistant packaging, batch identification, ingredient disclosure, age controls or recall mechanisms.
The risk is particularly serious for minors, as these products can resemble ordinary confectionery. Inexperienced adult consumers may also overconsume due to delayed onset and unclear potency.
This is no longer an abstract policy issue, it is a practical public health and consumer safety concern requiring urgent attention. South Africa already applies robust product safety, labelling, batch control and recall principles across medicines, food, alcohol and tobacco. Cannabis edibles should not remain outside a coherent safety framework.
The current regulatory position creates a structural contradiction in which adult private cannabis use is recognised in law, while the broader systems governing product standards, packaging, dosage disclosure, traceability and lawful market participation remain incomplete.
As a result, products continue circulating in practice without a fully integrated consumer safety framework.
Importantly, the public health concern is not driven solely by the existence of cannabis products themselves, but by the absence of a coherent system that defines and enforces standards relating to potency, dosage, testing, labelling, packaging, traceability and responsible distribution.
At present, the broader cannabis value chain remains only partially regulated.
While cultivation and private adult use are recognised within defined legal parameters, the systems governing product circulation, standardisation, consumer protection and edible product controls remain fragmented. This regulatory gap increasingly affects public safety outcomes.
In support of this position, H3 Legal Solutions, in conjunction with HealthPath24, has developed a proposed Cannabis Packaging White Paper, attached herewith for consideration.
The White Paper examines emerging international packaging standards and proposes a practical South African packaging and traceability framework aligned to public health, consumer safety and responsible market participation principles.
The White Paper highlights several key packaging and compliance principles, including:
➢ Child-resistant and tamper-evident packaging standards;
➢ Standardised dosage and potency disclosure;
➢ Batch identification and traceability systems;
➢ QR-linked digital information and product verification;
➢ Responsible marketing and warning requirements;
➢ Integrated recyclability and environmental compliance considerations;
➢ Standardised disposal and safety labelling;
➢ Track-and-trace integration capability;
➢ Packaging minimisation and material-efficiency principles; and
➢ The integration of product safety, traceability and environmental accountability within a unified packaging framework.
The White Paper further highlights emerging international developments under the European Union Packaging and Packaging Waste Regulation (EU) 2025/40, which increasingly treats packaging as part of a broader regulatory compliance system incorporating traceability, lifecycle accountability, standardised labelling and recyclability requirements.
We further welcome the National Consumer Commission’s initiative to introduce track-and-trace regulations under the Consumer Protection Act. As reported by Business Day on 7 May 2026, the proposed system, aimed at combating illicit trade in pharmaceuticals, tobacco, alcohol and food products, is expected to become a significant future component of cannabis compliance architecture.
Such a system would materially strengthen consumer safety, improve sourcing verification, support effective product recalls, enhance regulatory visibility and assist in distinguishing accountable operators from illicit or untraceable supply chains. Importantly, it also provides a practical pathway toward improved accountability and formalisation within an already active market environment.
International public health approaches increasingly favour risk differentiation, harm reduction, product standards, age restrictions and traceability over unregulated market conditions. A structured cannabis packaging and edible safety framework would align South Africa more closely with emerging international best practice focused on consumer protection and public health outcomes.
We believe the combination of improved packaging standards and track-and-trace capability offers a practical and immediate pathway to protect public health while simultaneously supporting the broader objectives of the National Cannabis Master Plan.
Accordingly, we respectfully propose that government consider the urgent development of an interim or transitional cannabis edible safety framework addressing, at minimum, the following:
• Child-resistant and tamper-evident packaging;
• Clear cannabis content and potency disclosure;
• Standardised dosage guidance;
• Warnings relating to delayed onset and overconsumption;
• Restrictions on packaging that imitates ordinary sweets or appeals to children;
• Batch identification and traceability requirements;
• Ingredient and allergen disclosure;
• Product recall capability;
• Age restriction and access control measures;
• Responsible-use education;
• Poison response and adverse incident reporting mechanisms; and
• Clear classification standards across medical, private-use, wellness, edible and prohibited product categories.
Our position is not that cannabis should be promoted without restriction. Our position is that products already circulating within society require appropriate controls to protect children, consumers, patients, families and communities.
We remain available to provide technical briefings, contribute to working groups, or assist with the development of interim safety standards relating to edible products, packaging, labelling and traceability systems.
Charl Botha B. Proc (S.A)
H3 LEGAL SOLUTIONS (CANNABIS STRATEGIC SPECIALISTS) / HEALTHPATH24
Email: charl@h3legal.co.za
Tel: 078 213 2947
https://www.h3legal.co.za
#
